Febuxostat Tablets

Closed Solicitation Posted

Solicitation number
SPE2D2-26-R-0012
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical seeks offers for Febuxostat tablets in two strengths (40 mg and 80 mg), with proposals due October 29, 2026. Amendment 0003, effective October 14, 2026, extended the closing deadline from October 15 to October 29 at 3:00 PM EST. No set-aside is used.

This is a requirements contract for commercial items with a one-year base period and four one-year options, for a maximum five-year term. Estimated annual quantities are 76,388 bottles of 40 mg strength and 36,627 bottles of 80 mg strength, in 30-count unit-of-use packaging. The contract will serve the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through Pharmaceutical Prime Vendor distribution networks. Place of performance is the contractor's facility; the contracting office is located in Philadelphia, Pennsylvania.

Evaluation uses Lowest Price Technically Acceptable methodology. Manufacturing facilities must be FDA-inspected and approved, and products must comply with FDA current Good Manufacturing Practices, include proper bar coding (GS1-128 or HIBCC standards), and be registered with RXNorm, First Data Bank, and Medi-Span within five days of award. The contract is subject to Trade Agreements Act restrictions. All pricing must be in U.S. dollars, exclusive of Federal Excise Tax, and must include a 0.5 percent cost recovery fee embedded in the offered price. Contractors must establish separate business-to-business agreements with each PPV contractor; the Government has no obligation to guarantee estimated quantities. Large business offerors must submit small business subcontracting plans. Performance begins 45 calendar days after award, with prices effective 15 days thereafter. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing; PSC is 6505, Drugs and Biologicals.

Notice text

SPE2D2-26-R-0012 Febuxostat Tablets Solicitation

Files

File Type Posted
SF30_SPE2D226R00120003.PDF PDF
SF30_SPE2D226R00120002.PDF PDF
SF30_SPE2D226R00120001.PDF PDF
SPE2D2-26-R-0012 Febuxostat Solicitation.pdf PDF

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
Febuxostat Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity